Mechanisms of antibiotic resistance in enterococci
Open accessAbstract
Multidrug-resistant (MDR) enterococci are important nosocomial pathogens and a growing clinical challenge. These organisms have developed resistance to virtually all antimicrobials currently used in clinical practice using a diverse number of genetic strategies. Due to this ability to recruit antibiotic resistance determinants, MDR enterococci display a wide repertoire of antibiotic resistance mechanisms including modification of drug targets, inactivation of therapeutic agents, overexpression of efflux pumps and a sophisticated cell envelope adaptive response that promotes survival in the human host and the nosocomial environment. MDR enterococci are well adapted to survive in the gastrointestinal tract and can become the dominant flora under antibiotic pressure, predisposing the severely ill and immunocompromised patient to invasive infections. A thorough understanding of the mechanisms underlying antibiotic resistance in enterococci is the first step for devising strategies to control the spread of these organisms and potentially establish novel therapeutic approaches.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Changing D-Ala for D-Ser does not remove any of the five hydrogen bonds between vancomycin and its target, but the serine hydroxyl group reduces affinity less markedly than the D-Lac replacement.
“Although the change of D-Ala for D-Ser does not remove any of the 5 hydrogen bonds between vancomycin and its target, the presence of the hydroxyl group of serine affects the interaction of the antibiotic with the precursors reducing its affinity, albeit less markedly than with the D-Lac replacement (74).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · see citing works
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724 · see citing works
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887 · see citing works
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776 · see citing works
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707 · see citing works
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095 · see citing works
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,052 · see citing works
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028 · see citing works
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008 · see citing works
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J. D., Thorne, G. M., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 563 · see citing works
Tetracyclines: Antibiotic action, uptake, and resistance mechanisms
Schnappinger, D., & Hillen, W. (1996) · Archives of Microbiology · doi:10.1007/s002030050339 · Cited by 484 · see citing works
Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains
Lebreton, F., van Schaik, W., Manson, A. L., Godfrey, P. A., Griggs, A. D., Mazumdar, V., Corander, J., Cheng, L., Saif, S., Young, S., et al. (2013) · mBio · doi:10.1128/mbio.00534-13 · Cited by 460 · see citing works
Modes and Modulations of Antibiotic Resistance Gene Expression
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., & Courvalin, P. M. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-06 · Cited by 424 · see citing works
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 411 · see citing works
Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions
Shinabarger, D. L., Marotti, K. R., Murray, R. W., Lin, A. H., Melchior, E. P., Swaney, S. M., Dunyak, D. S., Demyan, W. F., & Buysse, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2132 · Cited by 382 · see citing works
Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., Diaz, L., Tran, T. T., Rincon, S., Barbu, E. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011138 · Cited by 377 · see citing works
Self-citationDeshpande, L. M., Fritsche, T. R., Moet, G. J., Biedenbach, D. J., & Jones, R. N. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.12.022 · Cited by 343 · see citing works
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338 · see citing works
Self-citationAminoglycoside Resistance in Enterococci
Chow, J. W. (2000) · Clinical Infectious Diseases · doi:10.1086/313949 · Cited by 332 · see citing works
Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S., Proctor, R. A., Sahl, H., Schrenzel, J., Xiong, Y. Q., & Bayer, A. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-07 · Cited by 320 · see citing works
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319 · see citing works
Fernández-Hidalgo, N., Almirante, B., Gavaldà, J., Gurgui, M., Peña, C., de Alarcón, A., Ruiz, J., Vilacosta, I., Montejo, M., Vallejo, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit052 · Cited by 311 · see citing works
Dubrac, S., Bisicchia, P., Devine, K. M., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06483.x · Cited by 308 · see citing works
Mechanisms of quinolone action and microbial response
Hawkey, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg207 · Cited by 290 · see citing works
Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.118-125.2005 · Cited by 283 · see citing works
The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria
Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D. L., Xiong, L., & Mankin, A. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.005 · Cited by 278 · see citing works
Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1845-1850.2002 · Cited by 263 · see citing works
Gene Dosage and Linezolid Resistance in <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i>
Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A., & Rice, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3334-3336.2002 · Cited by 263 · see citing works
Schatz, A., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-57-14769 · Cited by 252 · see citing works
VanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405
Fines, M., Périchon, B., Reynolds, P. E., Sahm, D. F., & Courvalin, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2161 · Cited by 240 · see citing works
Mendes, R. E., Deshpande, L. M., Castanheira, M., DiPersio, J. R., Saubolle, M. A., & Jones, R. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00231-08 · Cited by 227 · see citing works
Macrolide Resistance Genes in Enterococcus spp
Portillo, A., Ruiz‐Larrea, F., Zarazaga, M., Alonso, A., Martínez, J. L., & Torres, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.967-971.2000 · Cited by 227 · see citing works
vanM , a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium
Xu, X., Lin, D., Yan, G., Ye, X., Wu, S., Guo, Y. P., Zhu, D., Hu, F., Zhang, Y., Wang, F., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-09 · Cited by 213 · see citing works
Jordan, S., Junker, A., Helmann, J. D., & Mascher, T. (2006) · Journal of Bacteriology · doi:10.1128/jb.00310-06 · Cited by 209 · see citing works
Tran, T. T., Panesso, D., Mishra, N. N., Mileykovskaya, E., Guan, Z., Munita, J. M., Reyes, J., Diaz, L., Weinstock, G. M., Murray, B. E., et al. (2013) · mBio · doi:10.1128/mbio.00281-13 · Cited by 192 · see citing works
Self-citationHackbarth, C. J., & Chambers, H. F. “. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1144 · Cited by 191 · see citing works
Genetic Basis for Daptomycin Resistance in Enterococci
Palmer, K. L., Daniel, A., Hardy, C., Silverman, J. A., & Gilmore, M. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00207-11 · Cited by 189 · see citing works
Beta-lactamase-producing enterococci
Murray, B. E. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2355 · Cited by 184 · see citing works
Díaz, L., Kiratisin, P., Mendes, R. E., Panesso, D., Singh, K. V., & Arias, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00419-12 · Cited by 182 · see citing works
Self-citationBacterial Evasion of Antimicrobial Peptides by Biofilm Formation
Otto, M. J. (2006) · Springer eBooks · doi:10.1007/3-540-29916-5_10 · Cited by 182 · see citing works
Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium
Costa, Y., Galimand, M., Leclercq, R., Duval, J., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1896 · Cited by 181 · see citing works
Sakoulas, G., Bayer, A. S., Pogliano, J., Tsuji, B. T., Yang, S.-J., Mishra, N. N., Nizet, V., Yeaman, M. R., & Moise, P. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05551-11 · Cited by 176 · see citing works
d -Ala- d -Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium
Lebreton, F., Depardieu, F., Bourdon, N., Fines-Guyon, M., Berger, P., Camiade, S., Leclercq, R., Courvalin, P. M., & Cattoir, V. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-11 · Cited by 171 · see citing works
The vanZ gene of Tn1546 from enterococcus faecium BM4147 confers resistance to teicoplanin
Arthur, M., Depardieu, F., Molinas, C., Reynolds, P. E., & Courvalin, P. M. (1995) · Gene · doi:10.1016/0378-1119(94)00851-i · Cited by 169 · see citing works
Mishra, N. N., Bayer, A. S., Tran, T. T., Shamoo, Y. E., Mileykovskaya, E., Dowhan, W., Guan, Z., & Arias, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043958 · Cited by 168 · see citing works
Self-citationBauer, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh125 · Cited by 163 · see citing works
Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin
Zhang, T., Muraih, J. K., Tishbi, N., Herskowitz, J., Victor, R. L., Silverman, J., Uwumarenogie, S., Taylor, S. D., Palmer, M., & Mintzer, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554444 · Cited by 162 · see citing works
Kristich, C. J., Wells, C., & Dunny, G. (2007) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0608742104 · Cited by 159 · see citing works
Hershberger, E., Donabedian, S., Konstantinou, K., & Zervos, M. J. (2004) · Clinical Infectious Diseases · doi:10.1086/380125 · Cited by 156 · see citing works
Novel Mechanism of β-Lactam Resistance Due to Bypass of DD-Transpeptidation in Enterococcus faecium
Mainardi, J., Legrand, R., Arthur, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909877199 · Cited by 153 · see citing works
Hancock, L. E., & Perego, M. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.23.7951-7958.2004 · Cited by 152 · see citing works
Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
Díaz, L., Tran, T. T., Munita, J. M., Miller, W. R., Rincón, S., Carvajal, L. P., Wollam, A., Reyes, J., Panesso, D., Rojas, N. L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02686-14 · Cited by 138 · see citing works
Self-citationArbeloa, A., Segal, H., Hugonnet, J., Josseaume, N., Dubost, L., Brouard, J., Gutmann, L., Mengin‐Lecreulx, D., & Arthur, M. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.5.1221-1228.2004 · Cited by 137 · see citing works
Locke, J. B., Hilgers, M. T., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01032-09 · Cited by 136 · see citing works
Boyd, D. A., Willey, B. M., Fawcett, D., Gillani, N., & Mulvey, M. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01516-07 · Cited by 135 · see citing works
Impact of Specific pbp5 Mutations on Expression of β-Lactam Resistance in Enterococcus faecium
Rice, L. B., Bellais, S., Carias, L. L., Hutton‐Thomas, R., Bonomo, R. A., Caspers, P., Page, M. G. P., & Gutmann, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3028-3032.2004 · Cited by 128 · see citing works
Tran, T. T., Panesso, D., Gao, H., Roh, J. H., Munita, J. M., Reyes, J., Diaz, L., Lobos, E. A., Shamoo, Y., Mishra, N. N., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-12 · Cited by 125 · see citing works
Self-citationFontana, R., Aldegheri, M., Ligozzi, M., López, H. M., Sucari, A., & Satta, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.1980 · Cited by 125 · see citing works
Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci
Courvalin, P. M., Carlier, C., & Collatz, E. (1980) · Journal of Bacteriology · doi:10.1128/jb.143.2.541-551.1980 · Cited by 119 · see citing works
Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline
Fluit, A. C., Florijn, A., Verhoef, J., & Milatović, D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1636-1638.2005 · Cited by 118 · see citing works
Munita, J. M., Panesso, D., Diaz, L., Tran, T. T., Reyes, J., Wanger, A., Murray, B. E., & Arias, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00509-12 · Cited by 118 · see citing works
Self-citationvanC Cluster of Vancomycin-Resistant Enterococcus gallinarum BM4174
Arias, C. A., Courvalin, P. M., & Reynolds, P. E. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1660-1666.2000 · Cited by 115 · see citing works
Self-citationTreatment of enterococcal endocarditis and bacteremia
Robbins, W. C., & Tompsett, R. R. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90273-2 · Cited by 111 · see citing works
A novel gentamicin resistance gene in Enterococcus
Chow, J. W., Zervos, M., Lerner, S. A., Thal, L. A., Donabedian, S. M., Jaworski, D. D., Tsai, S., Shaw, K. J., & Clewell, D. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.511 · Cited by 109 · see citing works
Adaptation of Enterococcus faecalis to Daptomycin Reveals an Ordered Progression to Resistance
Miller, C. A., Kong, J., Tran, T. T., Arias, C. A., Saxer, G., & Shamoo, Y. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-13 · Cited by 103 · see citing works
Self-citationCspA from Borrelia burgdorferi Inhibits the Terminal Complement Pathway
Hallström, T., Siegel, C., Mörgelin, M., et al. (2013) · mBio · doi:10.1128/mbio.00481-13 · Cited by 103 · see citing works
Aminoglycoside-Inactivating Enzymes in Clinical Isolates of Streptococcus Faecalis
Krogstad, D. J., Korfhagen, T. R., Moellering, R. C., Wennersten, C. B., Swartz, M. N., Perzyński, S., & DAVIES, J. E. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109149 · Cited by 100 · see citing works
Comenge, Y., Quintiliani, R., Li, L., Dubost, L., Brouard, J., Hugonnet, J., & Arthur, M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.24.7184-7192.2003 · Cited by 99 · see citing works
A New High-Level Gentamicin Resistance Gene, aph(2")-Id , in Enterococcus spp
Tsai, S. F., Zervos, M., Clewell, D. B., Donabedian, S. M., Sahm, D. F., & Chow, J. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1229 · Cited by 97 · see citing works
Role of a qnr -Like Gene in the Intrinsic Resistance of Enterococcus faecalis to Fluoroquinolones
Arsene, S., & Leclercq, R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00274-07 · Cited by 96 · see citing works
Mechanisms of Resistance to Imipenem and Ampicillin in Enterococcus faecalis
Ono, S., Muratani, T., & Matsumoto, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2954-2958.2005 · Cited by 96 · see citing works
vanE Gene Cluster of Vancomycin-Resistant Enterococcus faecalis BM4405
Abadía-Patiño, L., Courvalin, P. M., & Périchon, B. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6457-6464.2002 · Cited by 96 · see citing works
Penicillin-Binding Protein 5 and Expression of Ampicillin Resistance in Enterococcus faecium
Rice, L. B., Carias, L. L., Hutton‐Thomas, R., Sifaoui, F., Gutmann, L., & Rudin, S. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1480-1486.2001 · Cited by 95 · see citing works
Baptista, M., Depardieu, F., Reynolds, P. E., Courvalin, P. M., & Arthur, M. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4401812.x · Cited by 94 · see citing works
Sakoulas, G., Rose, W., Nonejuie, P., Olson, J., Pogliano, J., Humphries, R., & Nizet, V. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02274-13 · Cited by 94 · cited 1× · see citing works
“Indeed, combinations of DAP with ampicillin, ceftriaxone and ceftaroline have been noted to be synergistic in vitro and to improve clinical outcomes of patients failing DAP therapy [71–73].”
BackgroundSifaoui, F., Arthur, M., Rice, L. B., & Gutmann, L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2594-2597.2001 · Cited by 94 · see citing works
Muraih, J. K., Harris, J., Taylor, S. D., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.10.027 · Cited by 93 · see citing works
A potential role for daptomycin in enterococcal infections: what is the evidence?
Cantón, R., Ruíz-Garbajosa, P., Chaves, R. L., & Johnson, A. P. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq087 · Cited by 93 · see citing works
Opsonic Antibodies to Enterococcus faecalis Strain 12030 Are Directed against Lipoteichoic Acid
Theilacker, C., Kaczyński, Z., Kropec, A., Fabretti, F., Sange, T., Holst, O., & Hüebner, J. (2006) · Infection and Immunity · doi:10.1128/iai.00570-06 · Cited by 92 · see citing works
Rifampicin resistance and its fitness cost in Enterococcus faecium
Enne, V. I. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh044 · Cited by 87 · see citing works
Werner, G., Gfrörer, S., Fleige, C., Witte, W., & Klare, I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn065 · Cited by 84 · see citing works
Dose Dependence of Emergence of Resistance to Linezolid inEnterococcus faecalisIn Vivo
Bourgeois‐Nicolaos, N., Massias, L., Couson, B., Butel, M., Andremont, A., & Doucet‐Populaire, F. (2007) · The Journal of Infectious Diseases · doi:10.1086/513876 · Cited by 83 · see citing works
Ray, A. J., Pultz, N. J., Bhalla, A., Aron, D. C., & Donskey, C. J. (2003) · Clinical Infectious Diseases · doi:10.1086/377451 · Cited by 81 · see citing works
Kandaswamy, K., Liew, T. H., Wang, C. Y., Huston-Warren, E., Meyer‐Hoffert, U., Hultenby, K. R., Schröder, J., Caparon, M. G., Normark, S. J., Henriques‐Normark, B., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319066110 · Cited by 79 · see citing works
Studies on the Mechanism of Intrinsic Resistance to -Lactam Antibiotics in Group D Streptococci
Williamson, R., Calderwood, S. B., Moellering, R. C., & Tomasz, A. (1983) · Microbiology · doi:10.1099/00221287-129-3-813 · Cited by 79 · see citing works
Reciprocal Regulation of Cephalosporin Resistance in Enterococcus faecalis
Kristich, C. J., Little, J. L., Hall, C. L., & Hoff, J. S. (2011) · mBio · doi:10.1128/mbio.00199-11 · Cited by 78 · see citing works
Ribosomal resistance of clinical enterococcal to streptomycin isolates
Eliopoulos, G. M., Farber, B. F., Murray, B. E., Wennersten, C. B., & Moellering, R. C. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.3.398 · Cited by 75 · see citing works
Arias, C. A., Martín‐Martinez, M., Blundell, T. L., Arthur, M., Courvalin, P. M., & Reynolds, P. E. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01294.x · Cited by 74 · see citing works
Self-citationGalloway-Peña, J., Rice, L. B., & Murray, B. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00099-11 · Cited by 74 · see citing works
Chen, H., Wu, W., Ni, M., Liu, Y., Zhang, J., Xia, F., He, W., Wang, Q., Wang, Z., Cao, B., et al. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.008 · Cited by 71 · see citing works
Schwarz, Š., Cardoso, M. R. D. I., & Wegener, H. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.3.580 · Cited by 71 · see citing works
Rice, L. B., Carias, L. L., Rudin, S. D., Hutton, R. A., Marshall, S. H., Hassan, M. O., Josseaume, N., Dubost, L., Marie, A., & Arthur, M. (2009) · Journal of Bacteriology · doi:10.1128/jb.01834-08 · Cited by 70 · see citing works
Munita, J. M., Mishra, N. N., Alvarez, D., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., Adachi, J. A., Bayer, A. S., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu642 · Cited by 70 · see citing works
Self-citationVanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis
Depardieu, F., Kolbert, M., Pruul, H., Bell, J. M., & Courvalin, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3892-3904.2004 · Cited by 70 · see citing works
Munita, J. M., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., & Arias, C. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00021-13 · Cited by 70 · cited 2× · see citing works
“More importantly, these changes were sufficient to abolish the in vitro bactericidal activity of DAP [60] and were associated with a clinical failure in a neutropenic patient with VRE bacteremia [70].”
BackgroundSelf-citationHigh-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17)
Werner, G., Fleige, C., Ewert, B., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.012 · Cited by 63 · see citing works
IreB, a Ser/Thr Kinase Substrate, Influences Antimicrobial Resistance in Enterococcus faecalis
Hall, C. L., Tschannen, M., Worthey, E. A., & Kristich, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01472-13 · Cited by 62 · see citing works
Snyder, A. H., Werth, B. J., Barber, K. E., Sakoulas, G., & Rybak, M. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku113 · Cited by 59 · see citing works
Use of Penicillin-binding Proteins for the Identification of Enterococci
Williamson, R., Gutmann, L., Horaud, T., Delbos, F., & Acar, J. F. (1986) · Microbiology · doi:10.1099/00221287-132-7-1929 · Cited by 59 · see citing works
Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium
Coudron, P. E., Markowitz, S. M., & Wong, E. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.5.1125 · Cited by 58 · see citing works
Hennig, S., & Ziebuhr, W. (2010) · Journal of Bacteriology · doi:10.1128/jb.00226-10 · Cited by 56 · see citing works
Isnard, C., Malbruny, B., Leclercq, R., & Cattoir, V. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01030-13 · Cited by 53 · see citing works
Duez, C., Zorzi, W., Sapunaric, F., et al. (2001) · Microbiology · doi:10.1099/00221287-147-9-2561 · Cited by 52 · see citing works
Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis
Grayson, M. L., Thauvin-Eliopoulos, C., Eliopoulos, G. M., Yao, J. D. C., DeAngelis, D. V., Walton, L., Woolley, J. L., & Moellering, R. C. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1792 · Cited by 51 · see citing works
MurAA Is Required for Intrinsic Cephalosporin Resistance of Enterococcus faecalis
Vesić, D., & Kristich, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05984-11 · Cited by 51 · see citing works
Galimand, M., Schmitt, E., Panvert, M., Desmolaize, B., Douthwaite, S. R., Méchulam, Y., & Courvalin, P. M. (2010) · RNA · doi:10.1261/rna.2233511 · Cited by 51 · see citing works
Sacco, E., Hugonnet, J., Josseaume, N., Cremniter, J., Dubost, L., Marie, A., Patin, D., Blanot, D., Rice, L. B., Mainardi, J., et al. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.07014.x · Cited by 48 · see citing works
Signoretto, C., Boaretti, M., & Canepari, P. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07207.x · Cited by 48 · see citing works
Genes homologous to glycopeptide resistance<i>van</i>A are widespread in soil microbial communities
Guardabassi, L., & Agersø, Y. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00270.x · Cited by 47 · cited 1× · see citing works
“apiaries [39].”
Muller, C. O., Breton, Y. L., Morin, T., et al. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2636-2645.2006 · Cited by 47 · see citing works
Theilacker, C., Kaczyński, Z., Kropec, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017839 · Cited by 46 · see citing works
Structural basis for streptogramin B resistance in Staphylococcus aureus by virginiamycin B lyase
Korczynska, M., Mukhtar, T. A., Wright, G. D., & Berghuis, A. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701809104 · Cited by 46 · see citing works
Fantin, B., Leclercq, R., Garry, L., & Carbon, C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.931 · Cited by 45 · see citing works
Novel Mechanism of Resistance to Glycopeptide Antibiotics in Enterococcus faecium
Cremniter, J., Mainardi, J., Josseaume, N., Quincampoix, J.-C., Dubost, L., Hugonnet, J., Marie, A., Gutmann, L., Rice, L. B., & Arthur, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606920200 · Cited by 44 · see citing works
Tetracycline resistance heterogeneity in Enterococcus faecium
Bentorcha, F., de Cespédès, G., & Horaud, T. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.808 · Cited by 42 · see citing works
Overcoming Bacterial Resistance by Dual Target Inhibition: The Case of Streptogramins
Canu, A., & Leclercq, R. (2001) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005014606152 · Cited by 42 · see citing works
Mutations in the β Subunit of RNA Polymerase Alter Intrinsic Cephalosporin Resistance in Enterococci
Kristich, C. J., & Little, J. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06077-11 · Cited by 42 · see citing works
Molecular analysis of streptogramin resistance in enterococci
Werner, G., Klare, I., & Witte, W. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00194 · Cited by 41 · see citing works
Havard, C. W. H., GARROD, L. P., & WATERWORTH, P. M. (1959) · BMJ · doi:10.1136/bmj.1.5123.688 · Cited by 39 · see citing works
Oyamada, Y., Ito, H., Fujimoto, K., et al. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46303-0 · Cited by 38 · see citing works
Pepper, K., Horaud, T., Bouguénec, C. L., et al. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.9.1394 · Cited by 37 · see citing works
Yasufuku, T., Shigemura, K., Shirakawa, T., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05549-11 · Cited by 37 · see citing works
Polyclonal Diffusion of Beta-Lactamase-Producing Enterococcus faecium
Sarti, M., Campanile, F., Sabia, C., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05640-11 · Cited by 37 · see citing works
Chenoweth, C., Robinson, K., & Schaberg, D. R. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1800 · Cited by 36 · see citing works
Breton, Y. S. L., Muller, C., Auffray, Y., & Rincé, A. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00390-07 · Cited by 33 · see citing works
Farina, C., Russello, G., Chinello, P., Pasticci, M. B., Raglio, A., Ravasio, V., Rizzi, M., Scarparo, C., Vailati, F., Suter, F., et al. (2011) · Chemotherapy · doi:10.1159/000330458 · Cited by 27 · see citing works
López, M., Tenorio, C., del Campo, R., et al. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.2.87 · Cited by 27 · see citing works
Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient
Cordina, C. M., Hill, R., Deshpande, A., Hood, J., & Inkster, T. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks122 · Cited by 25 · see citing works
Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium
Rand, K. H., Houck, H., & Silverman, J. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm045 · Cited by 24 · see citing works
Boumghar-Bourtchaï, L., Dhalluin, A., Malbruny, B., Galopin, S., & Leclercq, R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01633-08 · Cited by 21 · see citing works
Millán, Á. S., Depardieu, F., Godreuil, S., & Courvalin, P. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00034-09 · Cited by 19 · see citing works
Munita, J. M., Arias, C. A., & Murray, B. E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit050 · Cited by 19 · see citing works
Self-citationTheponAGene ofEnterococcus faecalisJH2-2 Codes for a Low-Affinity Class A Penicillin-Binding Protein
Duez, C., Hallut, S., Rhazi, N., et al. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.13.4412-4416.2004 · Cited by 13 · see citing works
Vancomycin-Dependent Enterococcal Strains: Case Report and Review
Yowler, C. J., Blinkhorn, R., & Fratianne, R. B. (2000) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200004000-00035 · Cited by 12 · see citing works
Díaz, L., Kontoyiannis, D. P., Panesso, D., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit138 · Cited by 12 · see citing works
Dual defensin strategy for targeting Enterococcus faecalis
Gilmore, M. S., Lebreton, F., & Tyne, D. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319939110 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782 · see citing works
Self-citationMolecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398 · see citing works
Mechanisms of antibiotic resistance
Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421 · see citing works
Self-citationZaheer, R., Cook, S. R., Barbieri, R., Goji, N., Cameron, A., Petkau, A., Polo, R. O., Tymensen, L., Stamm, C., Song, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61002-5 · Cited by 262 · see citing works
Antibiotic resistance propagation through probiotics
Daniali, M., Nikfar, S., & Abdollahi, M. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1825682 · Cited by 90 · see citing works
Initial safety evaluation of <i>Enterococcus faecium</i> LBB.E81
Urshev, Z., & Yungareva, T. (2021) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2020.1840438 · Cited by 17 · see citing works
- Authors
- Miller, W. R., Munita, J. M., & Arias, C. A.
- Affiliations
- Universidad del Desarrollo (CL)
- Venue
- Expert Review of Anti-infective Therapy
- Publisher
- Informa UK Limited
- Published
- 2014-09-09
- Volume
- 12
- Issue
- 10
- Pages
- 1221-1236
- ISSN
- 1478-7210 (ISSN-L)
- 1744-8336
- PMC
- PMC4433168
- OpenAlex
- W2167956674
- Cited by
- 772
- References
- 136
- Citations by year
- 2026: 56 · 2025: 98 · 2024: 88 · 2023: 89 · 2022: 108 · 2021: 94 · 2020: 86 · 2019: 61 · 2018: 49 · 2017: 21 · 2016: 17 · 2015: 5
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Expert Review of Anti-infective Therapy (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI093749)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- antibiotic resistance, Enterococcus, multidrug resistance, drug target modification, antibiotic inactivation, efflux pumps, nosocomial pathogens, intestinal colonization, invasive infections, antimicrobial resistance determinants
- MeSH terms
- Anti-Bacterial Agents, Humans, Models, Biological, Gram-Positive Bacterial Infections, Enterococcus, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review